NCT07634692 An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia Status COMPLETED Phase N/A
NCT07629960 A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations Status RECRUITING Phase PHASE1/PHASE2
NCT07624513 Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE3
NCT07621653 Post Marketing Surveillance Study for MenQuadfi® [Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjugate Vaccine] Administered in Participants Aged 6 Weeks to 55 Years in Republic of Korea Status RECRUITING Phase N/A
NCT07615179 Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD) Status COMPLETED Phase N/A
NCT07615166 Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine Clinical Practice Status COMPLETED Phase N/A
NCT07612878 The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry Status NOT_YET_RECRUITING Phase N/A
NCT07606508 Follow-up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment. Status RECRUITING Phase N/A
NCT07600151 Etenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07587658 This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization Status NOT_YET_RECRUITING Phase PHASE4
NCT07556159 A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice Status RECRUITING Phase N/A
NCT07547436 A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis Status SUSPENDED Phase PHASE2
NCT07516418 Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age Status RECRUITING Phase PHASE1
NCT07500298 Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer Status RECRUITING Phase PHASE1
NCT07484230 A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps Status WITHDRAWN Phase PHASE3
NCT07479979 Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT07467564 The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis Status RECRUITING Phase N/A